Assignee
GALECTO BIOTECH AB
DK·25 granted patents·17 pending applications·78 citations·filing 2013–2022
Top patents by PatentIndex Score
42 records- 0196US11377464B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2020·Granted Jul 5, 2022·6 cites·27 claims
- 0293US11827666B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2021·Granted Nov 28, 2023·2 cites·13 claims
- 0392US10988502B2Alpha-D-galactoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2017·Granted Apr 27, 2021·8 cites·24 claims
- 0491US11939349B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2022·Granted Mar 26, 2024·2 cites·16 claims
- 0590US11046725B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2019·Granted Jun 29, 2021·8 cites·7 claims
- 0690US9688713B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2015·Granted Jun 27, 2017·4 cites·7 claims
- 0789US10526360B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2019·Granted Jan 7, 2020·7 cites·6 claims
- 0888US11447517B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2019·Granted Sep 20, 2022·6 cites·19 claims
- 0988US10774102B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2016·Granted Sep 15, 2020·7 cites·28 claims
- 1086US9580456B2Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosisGALECTO BIOTECH AB·Filed 2013·Granted Feb 28, 2017·8 cites·19 claims
- 1185US10253059B2Hybrid galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2015·Granted Apr 9, 2019·3 cites·22 claims
- 1282US10889610B2Alpha-D-galactoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2017·Granted Jan 12, 2021·4 cites·20 claims
- 1379US11919921B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2022·Granted Mar 5, 2024·0 cites·7 claims
- 1479US9353141B2Galectoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2013·Granted May 31, 2016·8 cites·19 claims
- 1576US10799482B2Polymorphic forms and processGALECTO BIOTECH AB·Filed 2019·Granted Oct 13, 2020·1 cites·12 claims
- 1676US10307403B2Polymorphic forms and processGALECTO BIOTECH AB·Filed 2018·Granted Jun 4, 2019·1 cites·17 claims
- 1774US10369136B2Polymorphic forms and processGALECTO BIOTECH AB·Filed 2016·Granted Aug 6, 2019·1 cites·16 claims
- 1873US10464964B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2016·Granted Nov 5, 2019·2 cites·20 claims
- 1973US2019375776A1Idiopathic pulmonary fibrosis-detection, monitoring, prediction methodsGALECTO BIOTECH AB·Filed 2019·Application pending·0 cites
- 2071US2021221836A1Idiopathic pulmonary fibrosis-detection, monitoring, prediction methodsGALECTO BIOTECH AB·Filed 2021·Application pending·0 cites
- 2166US2017275326A1Idiopathic pulmonary fibrosis-detection, monitoring, prediction methodsGALECTO BIOTECH AB·Filed 2017·Application pending·0 cites
- 2264US2022257628A1Once-daily treatment of pulmonary fibrosisGALECTO BIOTECH AB·Filed 2022·Application pending·0 cites
- 2358US2014171630A1Novel synthesis of galactoside inhibitorsGALECTO BIOTECH AB·Filed 2014·Application pending·0 cites
- 2456US2024309038A1Novel galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2021·Application pending·0 cites
- 2556US2024059728A1Novel galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2022·Application pending·0 cites
- 2656US2014011765A1Novel synthesis of galactoside inhibitorsGALECTO BIOTECH AB·Filed 2013·Application pending·0 cites
- 2755US2024287122A1Novel galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2021·Application pending·0 cites
- 2854US2024132531A1Novel galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2021·Application pending·0 cites
- 2953US11406655B2Once-daily treatment of pulmonary fibrosisGALECTO BIOTECH AB·Filed 2015·Granted Aug 9, 2022·0 cites·5 claims
- 3053US10800804B2Hybrid galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2018·Granted Oct 13, 2020·0 cites·20 claims
- 3152US2023137160A1Large scale process for preparing 1,2,4, 6-tetra-o-acetyl-3-azido-3-deoxy-d-galactopyranosideGALECTO BIOTECH AB·Filed 2021·Application pending·0 cites
- 3251US12441755B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2020·Granted Oct 14, 2025·0 cites·11 claims
- 3350US12441754B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2020·Granted Oct 14, 2025·0 cites·17 claims
- 3450US2014200190A1Novel galactoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2014·Application pending·0 cites
- 3549US2022251132A1Large scale process of 3,3'-dideoxy-3,3'-bis-[4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl]-1,1'-sulfanediyl-di-beta-d-galactopyranosideGALECTO BIOTECH AB·Filed 2020·Application pending·0 cites
- 3648US12410207B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2020·Granted Sep 9, 2025·0 cites·16 claims
- 3748US2021380623A1Prodrug galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2019·Application pending·0 cites
- 3847US2023063538A1Large scale processGALECTO BIOTECH AB·Filed 2020·Application pending·0 cites
- 3945US12497428B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2019·Granted Dec 16, 2025·0 cites·12 claims
- 4045US2022064204A1Amorphous form of 5-bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]-1-thio-alpha-d-galactopyranosideGALECTO BIOTECH AB·Filed 2019·Application pending·0 cites
- 4137US10730902B21,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectinsGALECTO BIOTECH AB·Filed 2016·Granted Aug 4, 2020·0 cites·20 claims
- 4229US2017095496A1Galactoside inhibitors for new usesGALECTO BIOTECH AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GALECTO BIOTECH AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →